Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

• Status: Completed
• Trial end date: 2013-09-10
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to provide subjects who participated in prior studies of EXC 001 the opportunity to have their hypertrophic scars surgically revised and treated with EXC 001.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Healthy adults who have participated in previous studies of EXC 001.

• Healthy adults who have chosen to have their scars revised.

Exclusion Criteria:

• Currently pregnant or pregnant during the 6 months prior to inclusion in the study, or breast feeding.

• Participation in another clinical trial within 30 days prior to the start of the study.